Medicenna Therapeutics Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $1,547,000 over the previous period. Total operating expenses were $16,303,000.
Profit Margin
| 2014 | 0 | -765 | |
|---|---|---|---|
| 2015 | 0 | -833 | |
| 2016 | 0 | -1.33M | |
| 2017 | 0 | -7.63M | |
| 2018 | 0 | -7.46M | |
| 2019 | 0 | -4.70M | |
| 2020 | 0 | -8.30M | |
| 2021 | 0 | -17.18M | |
| 2022 | 0 | -22.64M | |
| 2023 | 0 | 1.54M |
MDNA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 9.30M | 14.71M | 10.87M | 5.86M | 3.01M | 5.09M | 4.22M | 771.40K | 766 | 860 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 16.30M | 22.47M | 17.39M | 8.24M | 4.72M | 7.42M | 7.69M | 1.19M | 833 | 767 |
Operating income | -16.30M | -22.3M | -17.18M | -8.20M | -4.72M | -7.38M | -7.66M | -1.19M | -829 | -762 |
Other income (expenses), net | 6.25M | -277K | -102K | -32.06K | 19.15K | -43.91K | -1.71M | -133.95K | -4 | -3 |
Income before tax | -10.04M | -22.57M | -17.28M | -8.27M | -4.70M | -7.46M | -7.63M | -1.33M | -833 | -765 |
Income tax expense | -11.59M | 69K | -106K | 32.27K | 19.25K | 40.62K | 60 | 441 | 0 | -3 |
Net income | 1.54M | -22.64M | -17.18M | -8.30M | -4.70M | -7.46M | -7.63M | -1.33M | -833 | -765 |
Earnings per share | ||||||||||
Basic EPS | 0.02 | -0.42 | -0.35 | -0.26 | -0.18 | -0.31 | -0.45 | -0.08 | -0.05 | -0.04 |
Diluted EPS | 0.02 | -0.42 | -0.35 | -0.26 | -0.18 | -0.31 | -0.45 | -0.08 | -0.05 | -0.04 |
| Data source | Data source |